People: C R Bard Inc (BCR)

BCR on New York Consolidated

146.95USD
24 Jul 2014
Price Change (% chg)

$1.12 (+0.77%)
Prev Close
$145.83
Open
$146.25
Day's High
$147.30
Day's Low
$145.08
Volume
578,580
Avg. Vol
743,171
52-wk High
$150.13
52-wk Low
$110.00

Search Stocks

Summary

Name Age Since Current Position

Timothy Ring

56 2003 Chairman of the Board, Chief Executive Officer

John Weiland

58 2005 President, Chief Operating Officer, Director

Christopher Holland

47 2012 Chief Financial Officer, Senior Vice President

Peter Kreindler

67 2013 Senior Vice President, General Counsel, Secretary

John DeFord

52 2007 Senior Vice President - Science, Technology and Clinical Affairs

Frank Lupisella

53 2006 Vice President, Controller

Bronwen Kelly

61 2002 Vice President - Human Resources

Jim Beasley

50 2009 Group Vice President

Patricia Christian

53 2014 Vice President - Quality, Regulatory and Medical Affairs

Timothy Collins

53 2008 Group Vice President

John Groetelaars

47 2013 Group Vice President

Sharon Luboff

51 2009 Group Vice President

Herbert Henkel

65 2002 Lead Independent Director

David Melcher

59 2013 Director

David Barrett

71 2009 Independent Director

Marc Breslawsky

71 1996 Independent Director

John Kelly

71 2009 Independent Director

Gail Naughton

58 2004 Independent Director

Tommy Thompson

72 2005 Independent Director

Anthony Welters

59 1999 Independent Director

Tony White

67 1996 Independent Director

Todd Garner

Vice President - Investor Relations

Biographies

Name Description

Timothy Ring

Mr. Timothy M. Ring is Chairman of the Board, Chief Executive Officer of C R Bard Inc. Mr. Ring is Chairman and Chief Executive Officer of C. R. Bard. Mr. Ring has served as Chairman and Chief Executive Officer of the Company since August 2003, having been Group President from April 1997 to August 2003, Group Vice President from December 1993 to April 1997 and Vice President-Human Resources from June 1992 to December 1993. He is also a director of Quest Diagnostics Incorporated. Mr. Ring was formerly a director of CIT Group Inc. Mr. Ring is a member of the Executive Committee. Mr. Ring is a Trustee of the Foundation of The University of Medicine & Dentistry of New Jersey. He holds a B.S. in Industrial and Labor Relations from Cornell University.

John Weiland

Mr. John H. Weiland is President, Chief Operating Officer and Director of C R Bard Inc. He joined President and Chief Operating Officer of C. R. Bard. Mr. Weiland has served as President and Chief Operating Officer of the Company since August 2003, having been Group President from April 1997 to August 2003 and Group Vice President from March 1996 to April 1997. Mr. Weiland joined C. R. Bard from Dentsply International, where he was a Senior Vice President, until March 1996. He is also a director of West Pharmaceutical Services, Inc. Mr. Weiland received a B.S. in Biology from DeSales University and an M.B.A. from New York University.

Christopher Holland

Mr. Christopher S. Holland is Chief Financial Officer, Senior Vice President of C R Bard, Inc. He joined Bard in 2012 as Senior Vice President and Chief Financial Officer. In July 2013, Mr. Holland assumed additional responsibilities for Bard Medical Division. Prior to joining Bard, he held executive positions at ARAMARK Corporation since 2003 and was most recently Senior Vice President, Finance and Treasurer. Previously, Mr. Holland held various positions at J.P. Morgan and Company, Inc., including Vice President, with responsibility for the medical device sector.

Peter Kreindler

Mr. Peter M. Kreindler is Senior Vice President, General Counsel and Secretary of C R Bard Inc.He joined Bard in 2013 as Senior Vice President, General Counsel and Secretary. Prior to joining Bard, Mr. Kreindler was a partner in the law firm of McDermott Will & Emery, LLP. Previously, Mr. Kreindler served as Senior Vice President and General Counsel for Honeywell International, Inc. for 18 years, and held positions with Coopers & Lybrand and in private practice as a litigator.

John DeFord

Dr. John A. DeFord, Ph.D., is Senior Vice President - Science, Technology and Clinical Affairs of C R Bard Inc. He joined Bard in 2004 as Vice President, Science & Technology after serving as Managing Director with Early Stage Partners, LLP (ESP), a venture capital fund, from 2002 until 2004. Before joining ESP he was President and CEO of Cook Incorporated, a privately-held medical device company. He was promoted to Senior Vice President-Science, Technology & Clinical Affairs in 2007.

Frank Lupisella

Mr. Frank Lupisella Jr., is Vice President and Controller of C R Bard Inc. He joined Bard in 1987 and has served in various capacities in the finance organization of the company. Mr. Lupisella served as Vice President and Controller of the Davol division from 1999 until 2005 when he was promoted to Assistant Corporate Controller, Manufacturing Operations. In 2006, he was elected to his present position of Vice President and Controller of the company.

Bronwen Kelly

Ms. Bronwen K. Kelly is Vice President - Human Resources of C R Bard Inc. Prior to joining Bard, she was with American Home Products as Vice President, Human Resources for the Global Agricultural Products Group. Previously, Ms. Kelly held positions with American Cyanamid Company, including Director, Human Resources for the Cyanamid International, Agricultural Products and Shulton USA divisions.

Jim Beasley

Mr. Jim C. Beasley is Group Vice President of C R Bard Inc. He joined Bard in 1989 as a territory sales manager for Bard Interventional Products. He has held a succession of management positions including President of Bard Access Systems division from 2003 to 2007 and President of Bard Peripheral Vascular division since 2007. In 2009, Mr. Beasley was promoted to Group Vice President and assumed responsibility for both divisions. In January 2012, Mr. Beasley assumed additional responsibilities for Bard’s businesses in Japan, Asia (excluding China) and Australia. In July 2013, Mr. Beasley was promoted to Group President and assumed additional responsibilities for Bard’s businesses in Latin America while continuing to be responsible for the Bard Access Systems and Bard Peripheral Vascular divisions.

Patricia Christian

Timothy Collins

Mr. Timothy P. Collins is Group Vice President of C R Bard Inc. He joined Bard in 1986 as a facilities planner with the USCI Division. Over the next 12 years, he held positions of increasing responsibility including Director of Operations for Diagnostic Cardiology. Concurrent with the sale of Bard’s cardiology business, Mr. Collins joined Medtronic Vascular in 1998 as Vice President/Business Unit Manager in Medtronic/AVE and was later appointed Vice President, Global Operations, Vascular. In 2003, Mr. Collins returned to Bard as President of the Bard Electrophysiology Division. In 2008, Mr. Collins was promoted to Group Vice President responsible for worldwide manufacturing operations and also assumed responsibility for the Electrophysiology Division, until its sale in November 2013. In January 2012, Mr. Collins assumed additional responsibility for Bard’s businesses in Canada. In July 2013, Mr. Collins was promoted to Group President and assumed additional responsibility for Bard’s businesses in Europe.

John Groetelaars

Mr. John P. Groetelaars is Group Vice President of C R Bard Inc.He joined Bard in 2008 as Vice President and General Manager of the Davol division. In 2009, Mr. Groetelaars was promoted to President of the Davol division. In July 2013, Mr. Groetelaars was promoted to Group Vice President and assumed additional responsibilities for Bard’s businesses in China, Asia and Australia while continuing to be responsible for Bard’s Davol division. Prior to joining Bard, he held positions of increasing responsibility with Boston Scientific Corporation from 2001 until joining Bard and having most recently served as General Manager and Vice President for UK, Ireland and Nordic Regions.

Sharon Luboff

Ms. Sharon M. Luboff is Group Vice President of C R Bard Inc. She joined Bard in 2004 as President of Bard Medical Division. She is responsible for Bard’s international businesses. Prior to joining Bard, Ms. Alterio held positions at Baxter Healthcare including Vice President, Global Therapeutic Marketing for its Renal Division. In January 2012, Ms. Alterio assumed responsibility for Bard Medical Division while continuing to be responsible for Bard’s businesses in Europe, Latin America and China.

Herbert Henkel

Mr. Herbert L. Henkel is Lead Independent Director of C R Bard Inc. He is Retired Chairman and Chief Executive Officer of Ingersoll-Rand Company. Mr. Henkel served as Chairman from February 2010 to June 2010, having been Chairman and Chief Executive Officer from May 2000 to February 2010, President and Chief Executive Officer from October 1999 to May 2000 and President and Chief Operating Officer from April to October 1999. Prior to that, Mr. Henkel served as President and Chief Operating Officer of Textron, Inc. from 1998 to 1999, having been President of Textron Industrial Products from 1995 to 1998. He is also a director of 3M Company and Allstate Corporation. Mr. Henkel was formerly a director of AT&T Corporation and Visteon Corporation. Mr. Henkel is lead director and is also a member of the Compensation Committee, the Executive Committee, the Finance Committee and the Governance Committee. He holds both a B.S. and an M.S. in engineering from Polytechnic University of New York, as well as an M.B.A. from Pace University, New York.

David Melcher

Lt. Gen. (Retd.) David F. Melcher is Director of C R Bard Inc. Mr. Melcher is currently the Chief Executive Officer and President of Exelis Inc. (a diversified, global aerospace, defense, information and technology services company). Lieutenant General (Ret.) Melcher has served as Chief Executive Officer and President of Exelis Inc. since November 2011, having been President of ITT Defense & Information Solutions from December 2008 until the spin-off of Exelis Inc. from ITT in October 2011. Mr. Melcher also served as Vice President of Strategy and Business Development for ITT Defense & Information Solutions from August 2008 to December 2008, following 32 years of distinguished service in the U.S. Army. He also serves on the Board of Directors and is a member of the Executive Committee of each of the National Defense Industrial Association and the Aerospace Industries Association. Mr. Melcher is a member of the Audit Committee, the Compensation Committee and the Finance Committee. Mr. Melcher holds a bachelor’s degree in civil engineering from the U.S. Military Academy at West Point and two Masters degrees, including one in business administration from Harvard University and another in public administration from Shippensburg University.

David Barrett

Dr. David M. Barrett, M.D. is Independent Director of C R Bard Inc. Dr. Barrett is Emeritus President and Chief Executive Officer of Lahey Clinic (a nonprofit, multispecialty healthcare organization). Dr. Barrett retired from his position as President and CEO of Lahey Clinic having served in this role from September 1999 to November 2010 and as a member of its Board of Trustees and Chair of the Board of Governors from September 1999 to November 2010, having been Chair of the Department of Urology of Mayo Clinic, Vice Chair of the Board of Governors, Trustee of the Mayo Foundation and a member of its Executive Committee since 1975. He is also an Adjunct Professor of Surgery at Dartmouth Medical School. Dr. Barrett is currently an Emeritus Trustee of the Lahey Clinic and the Mayo Clinic. Dr. Barrett was formerly a director of ProUroCare Medical, Inc. Dr. Barrett is a member of the Audit Committee, the Regulatory Compliance Committee, and the Science and Technology Committee. Dr. Barrett received his B.A. from Albion College and his M.D. from Wayne State University School of Medicine.

Marc Breslawsky

Mr. Marc C. Breslawsky is Independent Director of C R Bard Inc. He is Retired Chairman and Chief Executive Officer of Imagistics International Inc. (formerly Pitney Bowes Office Systems) (document imaging solutions). Mr. Breslawsky served as Chairman and Chief Executive Officer of Imagistics International Inc. from December 2001 to December 2005, having been President and Chief Operating Officer of Pitney Bowes Inc. from 1996 to 2001, Vice Chairman from 1994 to 1996 and President of Pitney Bowes Office Systems from 1990 to 1994. He is also a director of The Brink’s Company. Mr. Breslawsky was formerly a director of Océ-USA Holding, Inc. and UIL Holdings Corporation. Mr. Breslawsky is a member of the Audit Committee, the Finance Committee, and the Science and Technology Committee. Mr. Breslawsky received his B.A. from New York University and is a Certified Public Accountant.

John Kelly

Mr. John C. Kelly is Independent Director of C R Bard Inc. He is Former Senior Vice President, Finance of Pfizer Inc. (pharmaceutical products). Mr. Kelly served as Senior Vice President, Finance of Pfizer Inc. from October 2009 to February 2010, having been Vice President and Controller of Wyeth (pharmaceutical and healthcare products) since March 2008. Mr. Kelly held various other positions, including Vice President, Finance Operations, since joining Wyeth in 2002. He is also a director of The Medicines Company. Mr. Kelly is a member of the Audit Committee and the Finance Committee. He is a certified public accountant and was an elected member of the Council of the American Institute of Certified Public Accountants. He earned both his B.S. in business administration and M.B.A. in international finance from Seton Hall University.

Gail Naughton

Dr. Gail K. Naughton, Ph.D. is Independent Director of C R Bard Inc. She is Chairman and Chief Executive Officer of Histogen, Inc. (regenerative medicine). Dr. Naughton has served as the Chairman and Chief Executive Officer of Histogen, Inc. since June 2007, having been Vice Chairman of Advanced Tissue Sciences, Inc. (ATS) (human-based tissue engineering) from March 2002 to October 2002, President from August 2000 to March 2002, President and Chief Operating Officer from 1995 to 2000 and co-founder and director since inception in 1991. Dr. Naughton also served as Dean of the College of Business Administration at San Diego State University from August 2002 to June 2011. Dr. Naughton was formerly a director of Celera Corporation and SYS Technologies, Inc. Dr. Naughton is a member of the Governance Committee, the Regulatory Compliance Committee, and the Science and Technology Committee. Dr. Naughton earned a B.S. from St. Francis College, Brooklyn, New York, and both an M.S. in Histology and a Ph.D. in Hematology from New York University Medical Center. She also holds an M.B.A. in Executive Management from the Anderson School at the University of California, Los Angeles.

Tommy Thompson

Gov. Hon. Tommy G. Thompson, J.D., is Independent Director of C R Bard Inc. Former U.S. Department of Health and Human Services Secretary. Mr. Thompson served as Secretary of the U.S. Department of Health and Human Services from January 2001 to January 2005, having been Governor of Wisconsin from November 1986 to January 2001. Mr. Thompson was a partner in the Akin Gump Strauss Hauer & Feld LLP law firm from March 2005 to January 2012, and he served as Independent Chairman of the Deloitte Center for Health Solutions from March 2005 to May 2009. Mr. Thompson was Chairman of the Board of Logistics Health, Inc. from January 2011 to June 2011, having been President of Logistics Health, Inc. from February 2005 to January 2011. He is also a director of CareView Communications, Inc., Centene Corporation, Cytori Therapeutics, Inc, United Therapeutics Corporation and Therapeutics MD, Inc. Mr. Thompson was formerly a director of AGA Medical Corporation, CNS Response, Inc., PURE Bioscience, SpectraScience, Inc., VeriChip Corporation and Voyager Pharmaceutical Corporation. His experience also includes his prior service as Chairman of the Board and President of Logistics Health, Inc., which provides third party administrative support to public and private employers requiring occupational medical services. Mr. Thompson is a recipient of the prestigious Horatio Alger Award. He is also a member of the District of Columbia and Wisconsin bars. Mr. Thompson received both his B.S. and his J.D. from the University of Wisconsin-Madison.

Anthony Welters

Mr. Anthony Welters is Independent Director of C R Bard Inc. He is Executive Vice President of UnitedHealth Group, Inc. (a diversified health and well-being company). Mr. Welters has served as Executive Vice President of UnitedHealth Group, Inc. since November 2006 and as a Member of the Office of the Chief Executive Officer since January 2011. He also served as President of the Public and Senior Markets Group from September 2007 to December 2010. Mr. Welters has also served as President and Chief Executive Officer of AmeriChoice Corporation, a UnitedHealth Group Company, and Chairman and Chief Executive Officer of AmeriChoice Corporation and its predecessor companies since 1989. He is also a director of Loews Corporation and West Pharmaceutical Services, Inc. Mr. Welters was formerly a director of Qwest Communications International, Inc. Mr. Welters is a member of the Compensation Committee, the Governance Committee and the Regulatory Compliance Committee. Mr. Welters holds a B.A. from Manhattanville College and a J.D. from New York University School of Law.

Tony White

Mr. Tony Lee White is Independent Director of C R Bard Inc. He is Retired Chairman, President and Chief Executive Officer of Applied Biosystems, Inc. (formerly Applera Corporation). Mr. White served as Chairman, President and Chief Executive Officer of Applied Biosystems, Inc. from September 1995 through November 2008. He is also a director of CVS Caremark Corporation and Ingersoll-Rand Company. Mr. White was formerly a director of AT&T Corporation. Mr. White is a member of the Compensation Committee, the Executive Committee and the Governance Committee. Mr. White received his B.A. from Western Carolina University.

Todd Garner

Options Compensation

Search Stocks